0001567619-18-004867.txt : 20181031
0001567619-18-004867.hdr.sgml : 20181031
20181031160426
ACCESSION NUMBER: 0001567619-18-004867
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181029
FILED AS OF DATE: 20181031
DATE AS OF CHANGE: 20181031
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BAUPOST GROUP LLC/MA
CENTRAL INDEX KEY: 0001061768
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33415
FILM NUMBER: 181150322
BUSINESS ADDRESS:
STREET 1: 10 ST JAMES AVE
STREET 2: SUITE 1700
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-210-8300
MAIL ADDRESS:
STREET 1: 10 ST JAMES AVE
STREET 2: SUITE 1700
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baupost Group GP, L.L.C.
CENTRAL INDEX KEY: 0001738693
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33415
FILM NUMBER: 181150323
BUSINESS ADDRESS:
STREET 1: 10 ST. JAMES AVENUE
STREET 2: SUITE 1700
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-210-8300
MAIL ADDRESS:
STREET 1: 10 ST. JAMES AVENUE
STREET 2: SUITE 1700
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KLARMAN SETH A
CENTRAL INDEX KEY: 0000899869
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33415
FILM NUMBER: 181150324
BUSINESS ADDRESS:
BUSINESS PHONE: 6172108300
MAIL ADDRESS:
STREET 1: 10 ST JAMES AVENUE
STREET 2: STE 1700
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Orexigen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001382911
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 651178822
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3344 N. TORREY PINES CT.
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: (858) 875-8600
MAIL ADDRESS:
STREET 1: 3344 N. TORREY PINES CT.
STREET 2: SUITE 200
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
doc1.xml
FORM 4
X0306
4
2018-10-29
0
0001382911
Orexigen Therapeutics, Inc.
OREXQ
0001061768
BAUPOST GROUP LLC/MA
10 ST. JAMES AVENUE
SUITE 1700
BOSTON
MA
02116
0
0
1
0
0001738693
Baupost Group GP, L.L.C.
10 ST. JAMES AVENUE
SUITE 1700
BOSTON
MA
02116
0
0
1
0
0000899869
KLARMAN SETH A
10 ST. JAMES AVENUE
SUITE 1700
BOSTON
MA
02116
0
0
1
0
Common Stock
2018-10-29
4
S
0
650000
.01
D
896339
I
See footnote 1 and 2
Common Stock
2018-10-31
4
S
0
896339
.01
D
0
I
See footnote 1 and 2
This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP"), and Seth A. Klarman (collectively, the "Reporting Persons"). Baupost is a registered investment adviser and acts as an investment adviser to various private investment limited partnerships. BG GP, as the Manager of Baupost, and Seth A. Klarman, as the Managing Member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended, of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.
(Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purpose of Section 16 or for any other
purpose.
Seth A. Klarman
2018-10-31
Seth A. Klarman
2018-10-31
Seth A. Klarman
2018-10-31